High risk and low prevalence diseases: Lemierre's syndrome

https://doi.org/10.1016/j.ajem.2022.08.050Get rights and content

Abstract

Introduction

Lemierre's syndrome is a serious condition that carries with it a high rate of morbidity and even mortality.

Objective

This review highlights the pearls and pitfalls of Lemierre's syndrome, including presentation, diagnosis, and management in the emergency department (ED) based on current evidence.

Discussion

Lemierre's syndrome is a condition marked by septic thrombophlebitis of the internal jugular vein (IJV), with the classic triad of pharyngotonsillitis, IJV thrombosis, and septic emboli resulting in metastatic abscess. It typically begins as pharyngitis, often caused by Fusobacterium necrophorum. Patients most commonly present with fever, recently diagnosed pharyngitis, and neck pain or swelling. Septic emboli may affect multiple organ systems, most commonly the pulmonary system. The disease should be considered in patients with prolonged symptoms of pharyngitis, pharyngitis that improves but then worsens, critically ill patients with pharyngitis, patients with pharyngitis and infection at a secondary site, and neck signs/symptoms. Diagnosis includes throat and blood cultures, as well as imaging to include computed tomography of the neck and chest with intravenous contrast. Additional imaging of other areas should be performed as clinically indicated. Initial management includes hemodynamic stabilization with intravenous fluids and vasopressors as needed, as well as broad-spectrum antibiotics. Anticoagulation for the primary thrombus and possible septic emboli is controversial and should be considered in a multidisciplinary approach with admission.

Conclusions

An understanding of Lemierre's syndrome can assist emergency clinicians in diagnosing and managing this potentially deadly disease.

Introduction

This article series addresses high risk and low prevalence diseases that are encountered in the emergency department (ED). Much of the primary literature evaluating these conditions is not emergency medicine focused. By their very nature, many of these disease states and clinical presentations have little useful evidence available to guide the emergency physician in diagnosis and management. The format of each article defines the disease or clinical presentation to be reviewed, provides an overview of the extent of what we currently understand, and finally discusses pearls and pitfalls using a question and answer format. This article will discuss Lemierre's syndrome, a constellation of findings centered around post-pharyngitis septic thrombophlebitis. This condition's low prevalence but high morbidity, as well as its variable atypical patient presentations and challenging diagnosis, makes it a high risk and low prevalence disease. The aim of this paper is to provide emergency clinicians with clinical knowledge concerning this rare but potentially lethal condition so that they can diagnose this condition expeditiously and provide acute stabilization and management.

Lemierre's syndrome most commonly refers to septic thrombophlebitis of the internal jugular vein (IJV), with the classic triad of pharyngotonsillitis, IJV thrombosis, and septic emboli resulting in metastatic abscess [1]. However, there is no standardized definition for the syndrome with variable criteria utilized throughout the literature [[2], [3], [4]]. The condition most commonly begins with an oropharyngeal infection, but other infections have been associated with the disease [1,[5], [6], [7]].

Andre Lemierre published a case series in 1936 of 20 patients (of which 18 died) with post-pharyngitis anaerobic sepsis and IJV thrombosis, although similar presentations were reported as early as 1898 [[8], [9], [10]]. Fusobacterium necrophorum, an obligate anaerobic gram negative rod often found as part of the normal oral flora, is the most common cause of Lemierre's syndrome, isolated in 48–82% of cases, as well as the most common cause of anaerobic septicemia originating from the oropharynx [2,4,5,8,[11], [12], [13]]. Fusobacterium necrophorum has several factors that increase its virulence including adhesins, endotoxins, leukotoxins, and hemolysins, which increase its ability to cause a necrotic abscess [[2], [3], [4], [5],10,13]. This microbe can also produce beta-lactamase [[2], [3], [4], [5],10,13]. Polymicrobial cases demonstrate that Fusobacterium necrophorum-produced leukotoxin can facilitate the growth of aerobic Streptococci and other microbes [3,10,14]. Other bacterial causes include streptococci, Eikenella corrodens, Klebsiella pneumonia, Bacteroides species, and Staphylococcus aureus [[14], [15], [16]]. Several reports propose that preceding localized infections, to include infectious mononucleosis caused by Epstein-Barr virus (EBV), weaken oropharyngeal tissue integrity and the local immune response, allowing for direct penetration and extension of the bacterial infection [8,10,11,13,15,[17], [18], [19], [20], [21]].

The causative microbe enters through the oropharyngeal mucosa via inflammation, trauma, or tissue destruction. The organism then spreads through deep connective cervical tissues into the local hematogenous and/or lymphatic supply, extending to the veins of the head and neck, most commonly the IJV [[5], [6], [7]]. The bacteria cause inflammation of the blood vessel wall and activate platelets and the coagulation cascade, leading to thrombus formation. This initial thrombus may result in septic emboli that affect other organs, most commonly the pulmonary system [13,22].

Large septic thrombus in the IJV and the propensity for metastatic septic emboli in Lemierre's syndrome create significant concerns for morbidity and mortality. The initially reported mortality of 90% dropped in the modern era largely due to early antibiotic use, but the current mortality rate remains significant, ranging from 2 to 18% [2,8,9,14,21,23,24]. Approximately 52% of patients require a prolonged hospital or intensive care unit (ICU) length of stay (median 25 days) [23]. Literatures suggests diffuse spread of septic emboli, most notably involving the lungs (37–100%), joints (11–27%), and brain (3%) [4,5,8,9,13,15,25,26]. There are no reported cases of a hemodynamically significant pulmonary embolism (PE) [4]. Limited data demonstrate up to 12% of patients experience a recurrence or clinical sequelae after hospital discharge, including cranial nerve palsies, paralysis, paresis, limb amputation, or blindness, and case reports describe airway compromise due to Lemierre's syndrome [2,4,27].

Overall, Lemierre's syndrome is rare, with an incidence of 0.8–3.6 cases per 1,000,000 per year [25,[28], [29], [30]]. However, rates are disproportionately concentrated in adolescent populations, with 14.4–16 cases per 1,000,000 per year in persons aged 16–24 years-old compared to 1.4 million cases per 1,000,000 per year in persons over 40 years-old [15,23,25,28,30]. Some studies limit Lemierre's syndrome diagnosis only to those who reported a preceding oropharyngeal infection, which likely underestimates the rate of diagnosis [2,29]. While some note there is an increasing rate of occurrence, particularly amongst younger populations, overall there are no consistent frequency trends [2,18,25,28,30,31]. Nevertheless, the incidence of Lemierre's syndrome may be increasing due to several factors, primarily the increasingly conservative use of antibiotics and decreased rates of tonsillectomies [2,13,18,29].

Section snippets

Emergency department presentation

Patients can present with a variety of signs and symptoms, and early in the course of the disease the presentation is nonspecific, resembling pharyngitis [16]. With its preponderance in younger populations, most cases involve an immunocompetent adolescent presenting with fever (92–100%), persistent or recently resolved pharyngitis with odynophagia that has worsened (82.5–94%), and neck pain and/or swelling (52–69%) [12,15,16,18,19,27,32]. Respiratory symptoms include dyspnea, cough, pleuritic

What infections may lead to Lemierre's syndrome?

While Fusobacterium necrophorum and other bacteria associated with pharyngotonsillitis are the primary cause of Lemierre's syndrome, these are common oral flora, and there are a number of other potential etiologies [11,40,41]. Recent or concurrent EBV has been associated with the disease and is likely a facilitator for bacterial penetration of compromised oropharyngeal tissue [4,11,12,19].

Fusobacterium necrophorum is generally found in significant portions of asymptomatic populations (21%) and

Conclusion

Despite its rarity and improved treatment regimens, Lemierre's syndrome is associated with significant morbidity and even mortality. Lemierre's syndrome is associated with septic thrombophlebitis, primarily of the IJV, and risk of disseminated septic emboli. History and examination can vary but largely center on an ill-appearing patient with neck signs and symptoms, possibly with ongoing pharyngitis. Evaluation includes throat and blood cultures with imaging. Ultrasound can identify IJV

CRediT authorship contribution statement

Brandon M. Carius: Writing – review & editing, Writing – original draft, Visualization, Conceptualization. Alex Koyfman: Writing – review & editing, Visualization, Validation, Conceptualization. Brit Long: Writing – review & editing, Writing – original draft, Visualization, Validation, Supervision, Conceptualization.

Declaration of Competing Interest

None.

Acknowledgements

BMC, BL, AK conceived the idea for this manuscript and contributed substantially to the writing and editing of the review. This manuscript did not utilize any grants, and it has not been presented in abstract form. This clinical review has not been published, it is not under consideration for publication elsewhere, its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published

References (59)

  • F. Castro-Marín et al.

    Diagnosis of Lemierre syndrome by bedside emergency department ultrasound

    J Emerg Med

    (Oct 2010)
  • Y. Kherabi et al.

    Gynecological Lemierre’s syndrome: A case report and literature review

    Rev Med Interne

    (Jul 2020)
  • M. Bordet et al.

    Mycotic pseudoaneurysm of carotid artery as a rare complication of Lemierre syndrome

    Mayo Clin Proc

    (Dec 2021)
  • M. Alifano et al.

    Lemierre’s syndrome with bilateral empyema thoracis

    Ann Thorac Surg

    (Mar 2000)
  • S. Habib et al.

    Septic emboli of the lung due to Fusobacterium necrophorum, a case of Lemierre’s syndrome

    Respir Med Case Rep

    (2019)
  • C. Jones et al.

    Lemierre’s syndrome presenting with peritonsillar abscess and VIth cranial nerve palsy

    J Laryngol Otol

    (Jun 2006)
  • L. Valerio et al.

    Head, neck, and abdominopelvic septic thrombophlebitis: current evidence and challenges in diagnosis and treatment

    Hamostaseologie.

    (Aug 2020)
  • O. Davies et al.

    Lemierre’s syndrome: diagnosis in the emergency department

    Emerg Med Australas

    (Dec 2012)
  • T. Riordan

    Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre’s syndrome

    Clin Microbiol Rev

    (Oct 2007)
  • B. Miller et al.

    Lemierre syndrome causing bilateral cavernous sinus thrombosis

    J Neuroophthalmol

    (Dec 2012)
  • M.R. Gore

    Lemierre syndrome: a meta-analysis

    Int Arch Otorhinolaryngol

    (Jul 2020)
  • M. Moretti et al.

    Lemierre’s syndrome in adulthood, a case report and systematic review

    Acta Clin Belg

    (Aug 2021)
  • W. Eilbert et al.

    Lemierre’s syndrome

    Int J Emerg Med

    (Oct 23 2013)
  • C. Sacco et al.

    Lemierre syndrome: clinical update and protocol for a systematic review and individual patient data meta-analysis

    Hamostaseologie.

    (Feb 2019)
  • S.J. Lee et al.

    Increasing Fusobacterium infections with Fusobacterium varium, an emerging pathogen

    PLoS One

    (2022)
  • Alves S, Stella L, Carvalho I, Moreira D. Lemierre's syndrome: a disguised threat. BMJ Case Rep Apr 23...
  • F. Campo et al.

    Antibiotic and anticoagulation therapy in Lemierre’s syndrome: case report and review

    J Chemother

    (Feb 2019)
  • M.I. Syed et al.

    Lemierre syndrome: two cases and a review

    Laryngoscope.

    (Sep 2007)
  • T. Riordan et al.

    Lemierre’s syndrome: more than a historical curiosa

    Postgrad Med J

    (Jun 2004)
  • Cited by (0)

    View full text